EpiVax receives $150,000 in phase II funding from Slater Center for Bio-Technology

by epivax3 | Mar 25, 2003 | News | 0 comments

Submit a Comment Cancel reply

Your email address will not be published. Required fields are marked *

Comment

Name *

Email *

Website